Healthcare and research are bound by a relationship as fundamental as that between blood and life. One sustains the other. While healthcare preserves life in the present, research safeguards its future by continually expanding the boundaries of scientific knowledge. Together, they constitute the twin pillars upon which modern medicine rests.
Dr Sami Ullah and Dr Shafat Ahmad Kenu
Healthcare and research are bound by a relationship as fundamental as that between blood and life. One sustains the other. While healthcare preserves life in the present, research safeguards its future by continually expanding the boundaries of scientific knowledge. Together, they constitute the twin pillars upon which modern medicine rests. Healthcare delivery broadly operates through two complementary systems: the public sector, primarily financed by governments to provide equitable access to healthcare irrespective of an individual’s economic status, and the private sector, funded through private investment and insurance mechanisms, which has become an increasingly dominant provider of sspecialisedand tertiary care. Although their funding models differ, their ethical obligation to advance medical knowledge remains the same.
The primary responsibility of every healthcare institution is to diagnose disease, alleviate suffering, and restore health. Yet, in the era of evidence-based medicine, this responsibility extends well beyond bedside care. Every hospital also functions as a repository of invaluable clinical experience capable of generating new knowledge that improves diagnostics, refines therapeutic strategies, informs public health policy, and shapes the future of patient care. Institutions that routinely benefit from decades of scientific discoveries, including research-derived medicines, diagnostics, medical technologies, and standardised treatment protocols, carry a reciprocal responsibility to contribute to the scientific enterprise that sustains them. Without such participation, healthcare institutions risk becoming passive consumers of innovation rather than active contributors to its advancement.
This issue has acquired renewed urgency in India, where recent analyses have highlighted the relatively modest research output of the private healthcare sector despite its substantial role in service delivery. Today, private hospitals are estimated to provide healthcare to nearly 60% of the country’s patients, making them indispensable partners in the national health system. Despite this, their contribution to peer-reviewed publications, clinical research, multicentre studies, disease registries, and translational science remains disproportionately limited when compared with the enormous volume of clinical material they manage. This disconnect represents one of the most underutilized scientific resources in Indian healthcare.
The consequences extend far beyond academic publication metrics. Every patient encounter generates data with the potential to illuminate disease epidemiology, evaluate treatment effectiveness, identify emerging health threats, improve healthcare quality, and guide evidence-informed policymaking. When these observations remain undocumented, unanalyzed, or unpublished, opportunities for scientific discovery are irretrievably lost. Millions of patient experiences that could collectively strengthen clinical practice and improve health outcomes simply disappear from the global evidence base. Ultimately, this is not merely a question of increasing publication counts or institutional rankings. It is an issue of professional responsibility and scientific stewardship. Modern medicine derives its credibility from rigorous research, systematic observation, ethical inquiry, and continuous validation. The medicines prescribed today, the surgical techniques routinely performed, the diagnostic algorithms clinicians rely upon, and the clinical guidelines that shape medical practice are all products of decades of sustained scientific investigation. Every healthcare institution that benefits from these advances bears a corresponding ethical obligation to participate in the continuous cycle of knowledge generation, critical evaluation, and innovation that underpins progress in medicine.
Historically, medical colleges, universities, and teaching hospitals have served as the principal engines of clinical research. Their long-standing contributions stem from established research ecosystems comprising institutional ethics committees, multidisciplinary expertise, academic collaborations, and dedicated research infrastructure. For decades, these institutions have translated scientific inquiry into innovations that have reshaped medical practice worldwide. The contemporary healthcare landscape has evolved considerably. Rapid epidemiological transitions, increasing disease complexity, an expanding pipeline of novel therapeutics, precision medicine, and digital health technologies have collectively outpaced the research capacity of academic institutions alone. The future of evidence-based medicine therefore depends upon a broader and more inclusive research ecosystem- one that actively incorporates private healthcare providers, which today manage a substantial proportion of patient care and increasingly deliver highly specialized clinical services.
Recognizing India’s expanding healthcare capabilities, the Government of India has, in recent years, accorded strategic priority to positioning the country as a global destination for Medical Value Travel (MVT) through the ‘Heal in India’ initiative. Simultaneously, the rapid expansion of medical colleges, super-specialty hospitals, advanced diagnostic facilities, and private healthcare enterprises has transformed India’s healthcare sector into one of the fastest-growing segments of the national economy. These developments have significantly enhanced the country’s clinical capacity, technological sophistication, and international visibility.
The scale of the private healthcare sector further reinforces its potential contribution to scientific discovery. Contemporary evidence indicates that private healthcare institutions account for nearly 78% of outpatient consultations and approximately 60% of hospital admissions across India. Their contribution is equally significant under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY), where private hospitals constitute nearly half of all empanelled healthcare facilities and account for more than half of hospitalization claims. Recent analyses have further demonstrated that participation in publicly financed health insurance programmes can remain financially sustainable for private healthcare providers while simultaneously expanding access to healthcare services.
These developments present an important opportunity. Institutions that manage such extensive and diverse patient populations possess an extraordinary reservoir of real-world clinical evidence capable of informing disease epidemiology, treatment effectiveness, healthcare quality, pharmacovigilance, health economics, and policy formulation. However, this potential remains substantially underutilized if clinical care is not accompanied by systematic research, robust data governance, and scholarly dissemination. The issue is therefore not whether private hospitals possess the capacity to contribute to medical science- they demonstrably do. Rather, the challenge lies in creating institutional cultures where research is regarded as an integral component of healthcare delivery rather than an optional academic exercise. Establishing dedicated research units, appointing qualified research personnel, strengthening institutional ethics mechanisms, investing in clinical registries, and fostering collaborations with universities and research organizations would enable private hospitals to transform routine clinical practice into meaningful scientific evidence.
As India’s healthcare sector continues to expand in scale, sophistication, and global relevance, its research enterprise must evolve in parallel. Clinical excellence and scientific excellence are not competing priorities; they are mutually reinforcing obligations. Hospitals that heal today’s patients also bear a professional responsibility to generate the knowledge that will improve the care of tomorrow’s patients. Jammu & Kashmir’s healthcare landscape is undergoing a notable transformation. In recent years, the region has witnessed increasing investment from both established local healthcare providers and nationally recognized hospital networks seeking to expand advanced medical services. This evolution reflects growing confidence in the region’s healthcare potential and offers an opportunity to redefine healthcare not only as a service sector but also as a centre for scientific discovery and innovation.
The expanding private healthcare footprint is evident across the Union Territory. Spread over its 20 districts, Jammu & Kashmir presently hosts a substantial network of empanelled private hospitals, with the highest concentration in the urban centres of Jammu and Srinagar, followed by districts such as Anantnag, Baramulla, Pulwama, Kupwara, Rajouri, Budgam, Samba, Kulgam, Shopian, Kathua, Poonch, Ramban, Ganderbal, Reasi, and Udhampur. Collectively, these institutions now deliver a considerable proportion of specialist consultations, diagnostic services, elective procedures, and tertiary care, complementing the public healthcare system and expanding healthcare access across the region.
This rapid institutional growth carries responsibilities that extend beyond clinical service delivery. Modern hospitals are no longer defined solely by the quality of care they provide today but also by the knowledge they generate for tomorrow. Every consultation, surgical procedure, diagnostic investigation, and therapeutic intervention creates valuable clinical information that, when systematically analysed, can improve healthcare quality, strengthen clinical guidelines, and inform public health policy. As the private healthcare sector continues to mature, integrating research into routine clinical practice should become an institutional priority rather than an academic aspiration.
Encouragingly, there are early indications that this transition has begun. Among the private healthcare institutions in the region, Paras Health, Srinagar (Plus Medicare Hospital) has initiated efforts to strengthen its research ecosystem alongside the expansion of advanced clinical services. Under the professional leadership of clinicians and administrators, including Dr. Murtuza Habib and Dr. Shafat Ahmad Kenu, the institution has demonstrated an appreciation of the importance of integrating scientific inquiry with patient care through initiatives that promote research capacity, academic collaboration, and evidence generation. Such efforts illustrate how private hospitals can simultaneously pursue clinical excellence and contribute to the advancement of medical knowledge. The institution’s recent approval for a Kidney Transplant Programme (KTP)- the first such approval granted to a private healthcare facility in Jammu & Kashmir- marks an important milestone in the region’s evolving healthcare capabilities. While advances in specialised clinical services deserve recognition, they also create unique opportunities for conducting outcome research, clinical audits, translational studies, patient registries, and quality improvement initiatives. These are the mechanisms through which sophisticated healthcare systems continuously evaluate, refine, and improve patient care.
The broader message extends well beyond any individual institution. The future of healthcare in Jammu & Kashmir will depend not only on expanding infrastructure but equally on cultivating a robust research culture across the private healthcare sector. Dedicated research units, trained clinical researchers, bio-statistical support, institutional ethics committees, data management systems, and collaborative partnerships with universities and research organisations should become integral components of modern hospital governance. Such investments would transform routine clinical practice into evidence that benefits patients far beyond the walls of individual hospitals. This transition is particularly important for Jammu & Kashmir because the region presents a distinctive epidemiological profile shaped by its geography, environment, genetics, lifestyle patterns, and sociocultural determinants of health. Evidence generated from other populations cannot always be extrapolated to local communities without validation. Locally conducted research is therefore indispensable for developing context-specific strategies for disease prevention, diagnosis, treatment, and health system planning.
The need becomes especially compelling in oncology. Cancer remains one of the fastest-growing areas of biomedical research globally, driven by rapid advances in molecular diagnostics, precision medicine, immunotherapy, and targeted therapeutics. As the burden of cancer and other non-communicable diseases continues to rise in Jammu & Kashmir, the region requires stronger participation in multicentre clinical trials, cancer registries, translational research, and long-term outcome studies. Private hospitals, with their expanding infrastructure and specialist expertise, are well positioned to contribute meaningfully to these initiatives while simultaneously providing patients with greater access to emerging therapeutic innovations.
Equally important is the growing challenge of substance use disorders. Jammu & Kashmir has witnessed evolving patterns of substance abuse characterised by increasing misuse of prescription medicines, synthetic opioids, and novel psychoactive substances. These developments present complex clinical, forensic, and public health challenges that require systematic investigation. Yet important questions concerning disease burden, treatment effectiveness, relapse trajectories, psychosocial determinants, and rehabilitation outcomes remain inadequately explored. By investing in multidisciplinary addiction research, private hospitals can generate evidence that informs healthcare delivery, public policy, mental health services, forensic practice, and community-based prevention strategies.
Ultimately, the future of healthcare excellence in Jammu & Kashmir will not be measured solely by the number of hospitals constructed or advanced technologies acquired. It will be measured by the region’s ability to convert everyday clinical experience into scientific evidence that improves patient care, informs policy, and contributes to the global body of medical knowledge. Clinical excellence and research excellence are not parallel ambitions; they are mutually reinforcing responsibilities. As the region’s private healthcare sector continues to evolve, it has an unprecedented opportunity to emerge not only as a provider of quality healthcare but also as a generator of knowledge that shapes the future of medicine.
The value of integrating research into routine healthcare extends far beyond increasing publication counts or improving institutional rankings. Evidence consistently shows that research-active hospitals are associated with stronger clinical governance, improved patient outcomes, enhanced quality assurance systems, and a culture of continuous learning and innovation. Such environments cultivate critical thinking among clinicians and provide young doctors, nurses, pharmacists, psychologists, laboratory scientists, and allied health professionals with opportunities to engage in scientific inquiry, evidence appraisal, and lifelong professional development. Importantly, meaningful medical research is not synonymous with expensive multicentre clinical trials alone. High-impact evidence can emerge from well-designed observational studies, disease registries, patient-reported outcome measures, clinical audits, epidemiological investigations, health services research, quality improvement initiatives, and interdisciplinary collaborations. With visionary leadership, appropriate governance, and modest investments in research infrastructure, hospitals can transform routine clinical practice into knowledge that benefits both present and future generations.
The question, therefore, is no longer whether private hospitals should participate in research, but whether modern healthcare systems can afford institutions that remain detached from knowledge generation. As medicine becomes increasingly data-driven, digitally connected, and guided by real-world evidence, hospitals that fail to embrace research risk limiting not only scientific progress but also their own capacity for innovation, quality improvement, and long-term clinical excellence.
Healthcare infrastructure and research capacity must therefore evolve in parallel. Every expansion in specialised services, advanced diagnostics, digital health technologies, and tertiary care should be accompanied by corresponding investments in research governance, institutional ethics committees, trained research personnel, clinical data systems, and collaborations with universities, public health agencies, and scientific organisations. Such integration strengthens transparency, promotes accountability, supports evidence-informed decision-making, and ultimately enhances the quality and safety of patient care.
India’s aspiration to become a global leader in healthcare cannot be realised through infrastructure alone. It requires an ecosystem in which government hospitals, academic institutions, research organisations, biotechnology partners, and private healthcare providers work collaboratively to transform everyday clinical encounters into scientific evidence capable of informing policy, advancing medical science, and improving health outcomes. The future of medicine will be shaped not only by how effectively we treat disease, but by how successfully we understand, predict, prevent, and personalise its management.
Private hospitals occupy a uniquely strategic position within this ecosystem. By serving a substantial proportion of India’s patient population while possessing advanced clinical expertise and access to diverse real-world data, they are exceptionally placed to accelerate translational research and strengthen evidence-based medicine. Investing in dedicated research programmes should therefore be viewed not as an optional academic exercise but as a core institutional responsibility that advances patient care, scientific discovery, and public health.
For Jammu & Kashmir, this opportunity carries particular significance. The region’s distinctive demographic, environmental, genetic, and sociocultural characteristics present important research questions that cannot always be answered through evidence generated elsewhere. Developing robust research ecosystems within both public and private hospitals would enable locally relevant solutions to emerge for chronic diseases, cancer, mental health disorders, infectious diseases, substance use disorders, and other evolving health challenges. Such evidence would not only improve regional healthcare delivery but also enrich national and global scientific literature. The evolution of private hospitals from centres of treatment to centres of discovery represents the next logical step in India’s healthcare journey. Institutions that generate knowledge alongside delivering care contribute not only to their own advancement but also to the resilience of the health system they serve. If India is to consolidate its position as a global healthcare destination, research must become an integral component of healthcare delivery rather than a peripheral academic pursuit. The future of healthcare will ultimately be measured not only by the number of lives saved today, but also by the knowledge generated to improve the lives of tomorrow.
Dr Sami Ullah is a Locum Research Consultant, and Dr Shafat Ahmad Kenu is fulltime Medical Superintendent at Paras Health, Srinagar
sa********@***il.com